Compare · CTSH vs MDRX
CTSH vs MDRX
Side-by-side comparison of Cognizant Technology Solutions Corporation (CTSH) and Veradigm Inc. (MDRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTSH and MDRX operate in EDP Services (Technology), so they compete in similar markets.
- CTSH is the larger of the two at $24.84B, about 9.9x MDRX ($2.52B).
- CTSH has been more active in the news (16 items in the past 4 weeks vs 3 for MDRX).
- CTSH has more recent analyst coverage (25 ratings vs 17 for MDRX).
- Company
- Cognizant Technology Solutions Corporation
- Veradigm Inc.
- Price
- -
- -
- Market cap
- $24.84B
- $2.52B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1998
- News (4w)
- 16
- 3
- Recent ratings
- 25
- 17
Cognizant Technology Solutions Corporation
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. The company operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. It offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; and enhanced compliance, integrated health management, claims investigative services, and patient experience, as well as services that drive operational improvements in areas, such as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. The company also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and cloud, interactive, and IoT services to information, media and entertainment, and communications and technology companies. Cognizant Technology Solutions Corporation was founded in 1994 and is headquartered in Teaneck, New Jersey.
Veradigm Inc.
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates in two segments: The Core Clinical and Financial Solutions; and The Data, Analytics and Care Coordination. The Core Clinical and Financial Solutions segment provides software applications for patient engagement, and integrated clinical and financial management solutions, which primarily include EHR-related software; and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Data, Analytics and Care Coordination segment offers practice reimbursement, and payer and life sciences solutions, which are primarily targeted at physician practices, payers, life sciences companies, and other healthcare stakeholders. Its solutions enable clients to transition, analyze, and coordinate care and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Latest CTSH
- Cognizant Named Aston Martin Aramco Formula One™ Team Global AI Services Partner
- SEC Form 10-Q filed by Cognizant Technology Solutions Corporation
- Cognizant Technology Solutions Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cognizant Reports First Quarter 2026 Results
- Cognizant to Acquire Astreya, Deepening Its AI-First Managed Services Capabilities at Scale
- Cognizant's Innovation Network a Fast Track to Enterprise Value
- Belcan Honored for Commitment to U.S. Navy Reservists
- Cognizant AI Lab Earns Three New U.S. Patents, Totaling 65 U.S. Patents and 88 International Patents
- Cognizant and Google Cloud Bring Agentic AI to Retail's Most Critical Customer Moments with Gemini Enterprise
- Cognizant and OpenAI Partner to Reshape Enterprise Software Engineering with Codex
Latest MDRX
- Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows
- Veradigm Doubles India-Based Employee Footprint, Adds New Managing Director
- Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer
- Veradigm Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Veradigm Inc.
- Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
- Veradigm to Release Business Update February 17th and Host Investor Call February 18th
- Amendment: SEC Form 8-A12G/A filed by Veradigm Inc.
- Veradigm Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Regulation FD Disclosure
- Veradigm Extends Stockholder Rights Plan